← Eichor
Condition: Early Small Ct1N0 Triple Negative Breast Cancer Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Early Small Ct1N0 Triple Negative Breast Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
Phase 2 · 3 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT05215106
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.